Omega 3 Basix Trademark Published for Opposition
Summary
The USPTO has published the trademark application for 'Omega 3 Basix' for opposition, with a publication date of March 22, 2026. The application covers dietary and nutritional supplements, including those containing enzymatically enhanced monoglyceride fish oils.
What changed
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Omega 3 Basix' (TM99492264) for opposition. This publication signifies that the application has passed initial examination and is now open to challenges from third parties for a statutory period. The goods listed include dietary and nutritional supplements, specifically those formulated with enzymatically enhanced monoglyceride fish oils for essential omega-3 fatty acids.
For entities involved in the dietary supplement market, this publication is a notice of a new trademark potentially entering the space. While this is not a final registration, it is a significant step in the trademark process. Companies should monitor the opposition period, which begins on the publication date, to identify any potential conflicts with their own existing trademarks or brands. No immediate compliance actions are required for most entities, but legal counsel should be consulted if there is a perceived conflict.
Source document (simplified)
← USPTO Trademark Applications
OMEGA 3 BASIX
Published for Opposition TM99492264 Kind: published Mar 22, 2026
Abstract
Dietary and nutritional supplements containing enzymatically enhanced monoglyceride fish oils providing essential omega-3 fatty acids to support overall health; Specifically formulated, prepared, and packaged dietary and nutritional supplements; dietary food supplements; dietary supplements
Filing Date
2025-11-12
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.